Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Ovid Therapeutics Inc. | President and COO | Employee Stock Option (right to buy) | 140K | Sep 9, 2024 | Direct | ||
Ovid Therapeutics Inc. | President and COO | Common Stock | 28.1K | Sep 9, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
OVID | Ovid Therapeutics Inc. | Sep 9, 2024 | 1 | $0 | 4 | Sep 11, 2024 | President and COO |
OVID | Ovid Therapeutics Inc. | Sep 9, 2024 | 0 | $0 | 3 | Sep 11, 2024 | President and COO |